NO20053076L - Farmasoytisk formulering med en uloselig aktiv forbindelse. - Google Patents
Farmasoytisk formulering med en uloselig aktiv forbindelse.Info
- Publication number
- NO20053076L NO20053076L NO20053076A NO20053076A NO20053076L NO 20053076 L NO20053076 L NO 20053076L NO 20053076 A NO20053076 A NO 20053076A NO 20053076 A NO20053076 A NO 20053076A NO 20053076 L NO20053076 L NO 20053076L
- Authority
- NO
- Norway
- Prior art keywords
- active compound
- pharmaceutical formulation
- insoluble active
- particulate
- less
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
En farmasøytisk formulering for pulmonal administrering omfatter et partikkelformig materiale som omfatter en partikkelformig aktiv forbindelse i en lipidmatriks, idet den aktive forbindelsen har en løselighet i vann på mindre enn 1,0 mg/ml. I én versjon har minst 90% av den partikkelformige aktive forbindelsen i den farmasøytiske formuleringen en geometrisk diameter på mindre enn 3 µm. I en annen versjon omfatter den uløselige aktive forbindelsen amphotericin B. Det partikkelformige materialet kan ha en størrelse og form som tillater at den trykkforstøvede farmasøytiske formuleringen blir levert til dypet av lungen.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43721002P | 2002-12-31 | 2002-12-31 | |
PCT/US2003/041703 WO2004060351A2 (en) | 2002-12-31 | 2003-12-31 | Pharmaceutical formulation with an insoluble active agent for pulmonary administration |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20053076D0 NO20053076D0 (no) | 2005-06-23 |
NO20053076L true NO20053076L (no) | 2005-09-13 |
Family
ID=32713146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20053076A NO20053076L (no) | 2002-12-31 | 2005-06-23 | Farmasoytisk formulering med en uloselig aktiv forbindelse. |
Country Status (18)
Country | Link |
---|---|
US (1) | US20040156792A1 (no) |
EP (1) | EP1589947B2 (no) |
JP (1) | JP2006513236A (no) |
KR (1) | KR20050095838A (no) |
CN (1) | CN1741789A (no) |
AU (1) | AU2003300137A1 (no) |
BR (1) | BR0317810A (no) |
CA (1) | CA2511523C (no) |
EA (1) | EA200501001A1 (no) |
ES (1) | ES2589578T5 (no) |
HU (1) | HUP0500846A3 (no) |
MX (1) | MXPA05007158A (no) |
NO (1) | NO20053076L (no) |
PL (1) | PL378270A1 (no) |
PT (1) | PT1589947T (no) |
TR (1) | TR200502522T2 (no) |
WO (1) | WO2004060351A2 (no) |
ZA (1) | ZA200505155B (no) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
US20060165606A1 (en) * | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
WO2001085136A2 (en) | 2000-05-10 | 2001-11-15 | Alliance Pharmaceutical Corporation | Phospholipid-based powders for drug delivery |
US8404217B2 (en) | 2000-05-10 | 2013-03-26 | Novartis Ag | Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use |
US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
EP1458360B1 (en) * | 2001-12-19 | 2011-05-11 | Novartis AG | Pulmonary delivery of aminoglycosides |
TW200503781A (en) * | 2002-12-31 | 2005-02-01 | Nektar Therapeutics | Aerosolizable pharmaceutical formulation for fungal infection therapy |
AU2004251623B2 (en) | 2003-05-28 | 2010-03-18 | Novartis Ag | Spray drying of an alcoholic aqueous solution for the manufacture of a water-in-soluble active agentmicroparticle with a partial or complete amino acid and/or phospholipid coat |
US8513204B2 (en) * | 2004-06-21 | 2013-08-20 | Novartis Ag | Compositions comprising amphotericin B, mehods and systems |
JP2008511637A (ja) | 2004-08-27 | 2008-04-17 | ザ ダウ ケミカル カンパニー | 致命的な感染症を治療する薬剤組成物の増強された供給 |
CA2623256A1 (en) * | 2005-09-29 | 2007-04-12 | Nektar Therapeutics | Receptacles and kits, such as for dry powder packaging |
ITMI20051999A1 (it) * | 2005-10-21 | 2007-04-22 | Eratech S R L | Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita' |
US20120128728A1 (en) * | 2005-12-28 | 2012-05-24 | Novartis Pharma Ag | Compositions Comprising Amphotericin B |
MX2008010721A (es) * | 2006-02-22 | 2008-09-01 | Mannkind Corp | Un metodo para mejorar las propiedades farmaceuticas de microparticulas que contienen dicetopiperazina y un agente activo. |
DE102006053375A1 (de) * | 2006-11-10 | 2008-05-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Mischung von Pulvern |
LT2170279T (lt) * | 2007-07-31 | 2018-03-12 | Otsuka Pharmaceutical Co., Ltd. | Aripiprazolo suspensijos ir liofilizuotos kompozicijos gamybos būdai |
EP2050437A1 (en) * | 2007-10-15 | 2009-04-22 | Laboratoires SMB | Improved pharmaceutical dry powder compositions for inhalation. |
PL220269B1 (pl) | 2008-04-21 | 2015-09-30 | Przedsiębiorstwo Produkcji Farmaceutycznej Hasco Lek Spółka Akcyjna | Kompozytowy nośnik leków proszkowych, sposób wytwarzania nośnika leków oraz urządzenie do wytwarzania cząstek nośnika kompozytowego |
WO2009140587A1 (en) * | 2008-05-15 | 2009-11-19 | Novartis Ag | Pulmonary delivery of a fluoroquinolone |
EP2413902B1 (en) | 2009-03-18 | 2019-07-17 | Incarda Therapeutics, Inc. | Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
EP3130396B1 (en) | 2009-03-27 | 2021-03-17 | Bend Research, Inc. | Spray-drying process |
GB0908129D0 (en) * | 2009-05-12 | 2009-06-24 | Innovata Ltd | Composition |
TR200904500A2 (tr) | 2009-06-10 | 2009-10-21 | Öner Levent | Ezetimib nanokristallerinin hazırlanması için yöntem ve farmasötik formülasyonları. |
EP2611529B1 (en) | 2010-09-03 | 2019-01-23 | Bend Research, Inc. | Spray-drying method |
PT2611530T (pt) | 2010-09-03 | 2019-05-09 | Bend Res Inc | Aparelho de secagem por pulverização e métodos de utilização do mesmo |
US9248584B2 (en) | 2010-09-24 | 2016-02-02 | Bend Research, Inc. | High-temperature spray drying process and apparatus |
CN103228266B (zh) * | 2010-10-29 | 2017-11-14 | 健康科学西部大学 | 三元混合物制剂 |
JOP20120023B1 (ar) | 2011-02-04 | 2022-03-14 | Novartis Ag | صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية |
JP2017505325A (ja) * | 2014-02-03 | 2017-02-16 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | 亜鉛プロトポルフィリンの微粒子送達のための製剤 |
JP6650933B2 (ja) | 2014-10-31 | 2020-02-19 | ベンド リサーチ, インコーポレイテッド | マトリックス中に分散された活性薬剤ドメインを形成するためのプロセス |
CN104587457B (zh) * | 2015-01-13 | 2017-03-22 | 广东海大畜牧兽医研究院有限公司 | 一种利用难溶或不溶蛋白、多肽抗原制备纳米微粒疫苗的方法 |
EP3393565B1 (en) * | 2015-12-24 | 2023-05-24 | Philip Morris Products S.A. | Nicotine particle capsule |
AU2017215189A1 (en) | 2016-02-01 | 2018-08-02 | Incarda Therapeutics, Inc. | Combining electronic monitoring with inhaled pharmacological therapy to manage cardiac arrhythmias including atrial fibrillation |
EP3621616A4 (en) | 2017-05-10 | 2021-01-13 | InCarda Therapeutics, Inc. | UNIT DOSE, AEROSOLS, KITS AND METHODS FOR TREATMENT OF HEART DISEASE BY PULMONAL ADMINISTRATION |
UA126238C2 (uk) * | 2017-06-28 | 2022-09-07 | Філіп Морріс Продактс С.А. | Ємність з частинками для використання з інгалятором |
EP3768378A4 (en) | 2018-03-22 | 2021-11-17 | InCarda Therapeutics, Inc. | INNOVATIVE METHOD OF SLOWING THE VENTRICULAR RATE |
GB201817865D0 (en) * | 2018-11-01 | 2018-12-19 | Nicoventures Trading Ltd | Aerosolisable formulation |
US11007185B2 (en) | 2019-08-01 | 2021-05-18 | Incarda Therapeutics, Inc. | Antiarrhythmic formulation |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US437210A (en) | 1890-09-30 | Electric street-car | ||
SE408265B (sv) * | 1975-12-12 | 1979-06-05 | Draco Ab | Anordning for koldioxiddriven endosaerosol, avsedd for inhalering |
US4247066A (en) * | 1978-02-21 | 1981-01-27 | General Dynamics Corporation | Airfoil variable cambering device and method |
IT1116047B (it) * | 1979-04-27 | 1986-02-10 | Sigma Tau Ind Farmaceuti | Dispositivo per la rapida inalazione di farmaci in polvere da parte di persone sofferenti di asma |
DE3634952A1 (de) * | 1986-10-14 | 1988-04-21 | Bayer Ag | Imidazo-pyrrolo-pyridin-derivate |
US5049388A (en) * | 1986-11-06 | 1991-09-17 | Research Development Foundation | Small particle aerosol liposome and liposome-drug combinations for medical use |
EP0592540B1 (en) * | 1991-07-02 | 2000-01-26 | Inhale, Inc. | Method and device for delivering aerosolized medicaments |
US5785049A (en) * | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
US6582728B1 (en) * | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
US6051256A (en) * | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
JP3388896B2 (ja) * | 1994-08-08 | 2003-03-24 | 株式会社日立ユニシアオートモティブ | 吸入式投薬器 |
DE4440337A1 (de) * | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit |
JP3708553B2 (ja) * | 1995-04-14 | 2005-10-19 | ネクター セラピューティクス | 向上した分散性を有する粉末型薬理組成物 |
US5855913A (en) * | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
US6503480B1 (en) * | 1997-05-23 | 2003-01-07 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
US5985309A (en) * | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
US5874064A (en) * | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
WO1998029096A1 (en) * | 1996-12-31 | 1998-07-09 | Inhale Therapeutic Systems | Aerosolized hydrophobic drug |
US20020017295A1 (en) * | 2000-07-07 | 2002-02-14 | Weers Jeffry G. | Phospholipid-based powders for inhalation |
AU756693B2 (en) * | 1997-09-29 | 2003-01-23 | Novartis Ag | Stabilized bioactive preparations and methods of use |
US6257233B1 (en) * | 1998-06-04 | 2001-07-10 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
WO2000001365A1 (en) † | 1998-06-30 | 2000-01-13 | Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) | Prolonged release ophthalmic compositions containing a fluoroquinolone |
US20010036481A1 (en) * | 1999-08-25 | 2001-11-01 | Advanced Inhalation Research, Inc. | Modulation of release from dry powder formulations |
WO2001085136A2 (en) † | 2000-05-10 | 2001-11-15 | Alliance Pharmaceutical Corporation | Phospholipid-based powders for drug delivery |
US6357490B1 (en) * | 2000-08-22 | 2002-03-19 | Advanced Inhalation Research, Inc. | System, method and apparatus for filling containers |
JP2004517127A (ja) † | 2000-12-21 | 2004-06-10 | ネクター セラピューティックス | ポリエン抗真菌剤の肺送達 |
-
2003
- 2003-12-31 KR KR1020057012444A patent/KR20050095838A/ko not_active Application Discontinuation
- 2003-12-31 WO PCT/US2003/041703 patent/WO2004060351A2/en active Application Filing
- 2003-12-31 EP EP03800395.0A patent/EP1589947B2/en not_active Expired - Lifetime
- 2003-12-31 ES ES03800395T patent/ES2589578T5/es not_active Expired - Lifetime
- 2003-12-31 EA EA200501001A patent/EA200501001A1/ru unknown
- 2003-12-31 PL PL378270A patent/PL378270A1/pl unknown
- 2003-12-31 CN CNA2003801091328A patent/CN1741789A/zh active Pending
- 2003-12-31 BR BR0317810-2A patent/BR0317810A/pt not_active IP Right Cessation
- 2003-12-31 CA CA2511523A patent/CA2511523C/en not_active Expired - Fee Related
- 2003-12-31 PT PT38003950T patent/PT1589947T/pt unknown
- 2003-12-31 AU AU2003300137A patent/AU2003300137A1/en not_active Abandoned
- 2003-12-31 JP JP2004564917A patent/JP2006513236A/ja not_active Withdrawn
- 2003-12-31 HU HU0500846A patent/HUP0500846A3/hu unknown
- 2003-12-31 MX MXPA05007158A patent/MXPA05007158A/es unknown
- 2003-12-31 TR TR2005/02522T patent/TR200502522T2/xx unknown
- 2003-12-31 US US10/750,934 patent/US20040156792A1/en not_active Abandoned
-
2005
- 2005-06-23 NO NO20053076A patent/NO20053076L/no not_active Application Discontinuation
- 2005-06-24 ZA ZA200505155A patent/ZA200505155B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1589947B8 (en) | 2016-08-24 |
HUP0500846A3 (en) | 2008-10-28 |
WO2004060351A2 (en) | 2004-07-22 |
ES2589578T5 (es) | 2019-07-23 |
ES2589578T3 (es) | 2016-11-15 |
ZA200505155B (en) | 2006-04-26 |
WO2004060351A3 (en) | 2004-09-30 |
HUP0500846A2 (en) | 2008-05-28 |
EP1589947A2 (en) | 2005-11-02 |
TR200502522T2 (tr) | 2005-09-21 |
NO20053076D0 (no) | 2005-06-23 |
EA200501001A1 (ru) | 2005-12-29 |
MXPA05007158A (es) | 2005-09-21 |
EP1589947B2 (en) | 2019-01-30 |
CA2511523A1 (en) | 2004-07-22 |
CN1741789A (zh) | 2006-03-01 |
US20040156792A1 (en) | 2004-08-12 |
BR0317810A (pt) | 2005-11-29 |
EP1589947B1 (en) | 2016-06-15 |
PL378270A1 (pl) | 2006-03-20 |
PT1589947T (pt) | 2016-09-05 |
JP2006513236A (ja) | 2006-04-20 |
AU2003300137A1 (en) | 2004-07-29 |
CA2511523C (en) | 2013-10-15 |
KR20050095838A (ko) | 2005-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20053076L (no) | Farmasoytisk formulering med en uloselig aktiv forbindelse. | |
UY30537A1 (es) | Formulaciones de flibanserina y metodo para fabricarlas | |
BR9503386A (pt) | Formulaçao farmacêutica comprimido dispersivel e processo para a fabricaçao de comprimidos dispersíveis contendo cloridrato de fluoxetina | |
NO20080827L (no) | Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon | |
NO20073959L (no) | Kinazolinderivat, fremgangsmate for fremstilling og anvendelse derav for inhibering av vekst av kreftceller | |
ATE355829T1 (de) | Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung | |
NO20081889L (no) | Fast vaksine formulering | |
RS52577B (en) | ONE-DAY OXYCODON FORMULATIONS | |
NO20082988L (no) | Vedvarende frigivningsformulering innbefattende oktreotid og to eller flere polylaktid-ko-glykolidpolymerer | |
ITRM20000294A0 (it) | Metodo di estrazione di prodotti ad attivita' farmaceutica da piante spermatofite, prodotti cosi' ottenuti e loro impiego in medicina, in pa | |
WO2006007354A3 (en) | A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device | |
ATE541562T1 (de) | Ibuprofen-suspension | |
TNSN97134A1 (fr) | Comprime de maleate de trimebutine pellicule | |
IT1314185B1 (it) | Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi | |
MXPA03005221A (es) | Composicion farmaceutica de dronedarona para administracion parenteral. | |
DE60102590D1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
NO20076108L (no) | Gelatin-inneholdende topikal sammensetning | |
RS52150B (en) | PELLETS CONTAINING VENLAFAKSIN HYDROCHLORIDE | |
NO20054417L (no) | Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter | |
UA89656C2 (ru) | Фармацевтическая композиция, которая диспергируется перорально, и способ ее приготовления | |
CO5550418A2 (es) | Formulaciones antihistaminicas para formas de dosificacion de capsula blanda | |
WO2007144902A8 (en) | Chewable bilayer tablet formulation | |
IL200447A0 (en) | Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby | |
WO2006033505A8 (en) | Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or cholic acid derivatives | |
WO1999066902A8 (en) | Injectable pharmaceutical formulations of partricin derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |